Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clinton Yam

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Radiology. Artificial Intelligence|November 6, 2024
Combining Biology-based and MRI Data-driven Modeling to Predict Response to Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast CancerCasey E Stowers, Chengyue Wu, Zhan Xu, et al.
Cancers|January 13, 2021
Alterations of NK Cell Phenotype in the Disease Course of Multiple MyelomaTatiana Pazina, Alexander W MacFarlane, Luca Bernabei, et al.
American Journal of Hematology|May 21, 2016
Unrelated donors are associated with improved relapse-free survival compared to related donors in patients with myelodysplastic syndrome undergoing reduced intensity allogeneic stem cell transplantationClinton Yam, Lisa Crisalli, Selina M Luger, et al.
Oncotarget|March 19, 2024
Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II-III breast cancerHaven R Garber, Sreyashi Basu, Sonali Jindal, et al.
Annals of Hepatology|October 23, 2017
Endoscopic Therapy is Effective for Recurrent Anastomotic Biliary Strictures after Orthotopic Liver TransplantationSun-Chuan Dai, David Goldberg, Amol Agarwal, et al.
Cancers|May 4, 2026
Characteristics and Clinical Outcomes of BRCA Germline Mutation Carriers with Advanced Breast Cancer Treated with PARP (Poly ADP-Ribose Polymerase) Inhibitors: A Single-Institution ExperienceFatma Nihan Akkoc Mustafayev, Elena Fountzilas, Mark F Munsell, et al.
Investigational New Drugs|January 28, 2018
A phase II study of tipifarnib and gemcitabine in metastatic breast cancerClinton Yam, Rashmi K Murthy, Vicente Valero, et al.
American Journal of Hematology|March 26, 2016
Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomasClinton Yam, Daniel J Landsburg, Kevin T Nead, et al.
American Journal of Cancer Research|March 21, 2020
Inhibition of c-MET upregulates PD-L1 expression in lung adenocarcinomaXian Sun, Chia-Wei Li, Wei-Jan Wang, et al.
Investigational New Drugs|October 13, 2018
A phase II study of imatinib mesylate and letrozole in patients with hormone receptor-positive metastatic breast cancer expressing c-kit or PDGFR-βClinton Yam, Rashmi K Murthy, Gaiane M Rauch, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Radiology. Artificial Intelligence|November 6, 2024
Combining Biology-based and MRI Data-driven Modeling to Predict Response to Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast CancerCasey E Stowers, Chengyue Wu, Zhan Xu, et al.
Cancers|January 13, 2021
Alterations of NK Cell Phenotype in the Disease Course of Multiple MyelomaTatiana Pazina, Alexander W MacFarlane, Luca Bernabei, et al.
American Journal of Hematology|May 21, 2016
Unrelated donors are associated with improved relapse-free survival compared to related donors in patients with myelodysplastic syndrome undergoing reduced intensity allogeneic stem cell transplantationClinton Yam, Lisa Crisalli, Selina M Luger, et al.
Oncotarget|March 19, 2024
Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II-III breast cancerHaven R Garber, Sreyashi Basu, Sonali Jindal, et al.
Annals of Hepatology|October 23, 2017
Endoscopic Therapy is Effective for Recurrent Anastomotic Biliary Strictures after Orthotopic Liver TransplantationSun-Chuan Dai, David Goldberg, Amol Agarwal, et al.
Cancers|May 4, 2026
Characteristics and Clinical Outcomes of BRCA Germline Mutation Carriers with Advanced Breast Cancer Treated with PARP (Poly ADP-Ribose Polymerase) Inhibitors: A Single-Institution ExperienceFatma Nihan Akkoc Mustafayev, Elena Fountzilas, Mark F Munsell, et al.
Investigational New Drugs|January 28, 2018
A phase II study of tipifarnib and gemcitabine in metastatic breast cancerClinton Yam, Rashmi K Murthy, Vicente Valero, et al.
American Journal of Hematology|March 26, 2016
Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomasClinton Yam, Daniel J Landsburg, Kevin T Nead, et al.
American Journal of Cancer Research|March 21, 2020
Inhibition of c-MET upregulates PD-L1 expression in lung adenocarcinomaXian Sun, Chia-Wei Li, Wei-Jan Wang, et al.
Investigational New Drugs|October 13, 2018
A phase II study of imatinib mesylate and letrozole in patients with hormone receptor-positive metastatic breast cancer expressing c-kit or PDGFR-βClinton Yam, Rashmi K Murthy, Gaiane M Rauch, et al.
Pageof 7